Citadel Upgrades UTHR To Add, Raises PT To $70
Citadel Securities has upgraded United Therapeutics Corporation (NASDAQ: UTHR) from Neutral to Add and has raised the price target to $70.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: citadel securities United Therapeutics Corp.Upgrades Price Target Analyst Ratings
